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Functional selectivity of G-protein-coupled receptors is believed to originate from ligand-
specific conformations that activate only subsets of signaling effectors. In this study, to
identify molecular motifs playing important roles in transducing ligand binding into distinct
signaling responses, we combined in silico evolutionary lineage analysis and structure-guided
site-directed mutagenesis with large-scale functional signaling characterization and non-
negative matrix factorization clustering of signaling profiles. Clustering based on the signaling
profiles of 28 variants of the β2-adrenergic receptor reveals three clearly distinct phenotypical
clusters, showing selective impairments of either the Gi or βarrestin/endocytosis pathways
with no effect on Gs activation. Robustness of the results is confirmed using simulation-based
error propagation. The structural changes resulting from functionally biasing mutations
centered around the DRY, NPxxY, and PIF motifs, selectively linking these micro-switches to
unique signaling profiles. Our data identify different receptor regions that are important for
the stabilization of distinct conformations underlying functional selectivity.
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G-protein-coupled receptors (GPCR) form the largestfamily of receptors involved in cellular signaling. Diverseexternal stimuli such as hormones, neurotransmitters,
metabolites, ions, and fatty acids are translated into a cellular
response via GPCR activation. The wide range of GPCR-regulated
cellular responses and disease associations with GPCR dysregu-
lation make this system a prime target for drug discovery and
development. In recent years, it has become evident that a single
GPCR can couple not only to one but to several different G-
protein subtypes leading to complex signaling profiles1,2. In
addition, G-protein-independent signaling of GPCRs has been
reported; primarily through βarrestins, which are also part of the
desensitization/endocytosis machinery3,4. It follows that indivi-
dual GPCRs have greater repertoires of cognate downstream
signaling partners than originally anticipated, making their sig-
naling more akin to a network than to a linear cascade. Fur-
thermore, ligands have been identified that bind to the same
GPCR but activate distinct and specific subsets of potential sig-
naling pathways5–9. This phenomenon, called ligand-biased sig-
naling or functional selectivity, has important implication for
drug discovery as it paves the way for the identification of ligands
that selectively target signaling pathways with therapeutic rele-
vance while sparing pathways that could underlie undesirable
effects. Currently, however, the possibility to rationally design
compounds with intended signaling profiles is limited by the
poorly understood molecular and structural determinants of
functional selectivity.
Translating extracellular ligand binding to intracellular sig-
naling relies on numerous small structural rearrangements of
receptors, and functional selectivity is believed to result from
differences in these rearrangements. Structural changes accom-
panying GPCR activation include an elongation and rotation of
TM5, an outward movement of TM6 and an inward movement of
TM710–13. It is thought that these conformational changes are
mediated by a conserved network of non-covalent contacts and
that these allosteric rearrangements define activation pathways14–
17. Such activation pathways include small groups of structurally
neighboring amino acids within the seven-helical transmembrane
domain common to GPCR that are called microswitches. These
include the DRY motif (D1303.49, R1313.50, Y1323.51), the toggle
switch (W2866.48), the NPxxY motif (N3227.49, P3237.50,
Y3267.53)18–20, and the PIF/connector motif (P2115.50, I1213.40,
F2826.44)13,21. However, in recent years, molecular dynamic
simulations and structural studies of GPCRs in solution have
shown that GPCR conformations are very dynamic and ligand
dependent22–26. These observations suggest that different
ensembles of receptor conformations might engage different
effectors and thereby induce functional selectivity.
Mutations in GPCRs, including both synthetic and naturally
occurring ones associated to diseases, have been shown to selec-
tively alter subsets of the signaling repertoire27–29. Such
mutagenesis-directed functional selectivity has even been intro-
duced in M3 muscarinic-based designer receptors exclusively
activated by designer drug (DREADD), resulting in a receptor
that could engage βarrestin but could no longer activate Gq in
response to the designer drug CNO30. However, connections
between structural perturbation and signaling bias are still poorly
understood. The available 3D structures of the β2-adrenergic
receptor (β2AR) in both active and inactive states10,11,21 provide
initial descriptions of receptor activation, which in combination
with site-directed mutagenesis, could inform us on the
structure–function basis of functional selectivity. The impact of
mutations depends on the sensitivity of the site that is mutated
and on the magnitude of the mutational substitution31. The effect
of both is captured by evolutionary action (EA), an equation that
models the sensitivity by the evolutionary trace (ET) method32,
and the substitution magnitude using amino acid transition log-
odds31. In theory, EA quantifies the evolutionary effect of geno-
type variations on functional responses. In practice, and spanning
molecular, clinical, and population genetic observations, muta-
tions with low EA value are mostly neutral when tested experi-
mentally, those with high EA value drastically affect protein
function, and those in between modulate function31,33–35. This
approach generalizes prior observations that ET identifies func-
tionally important (i.e., sensitive sequence) positions31,36–40. In
GPCRs, mutations specifically targeted to the most evolutionary
sensitive positions rewired ligand specificity of the D2 dopamine
receptor by single- and multiple-site mutations37,41 and separated
G-protein activation from βarrestin signaling by a triple-site
mutation28,42. By considering the substitution magnitude in
addition to site sensitivity, EA can now quantify the effect of
specific mutations more precisely, suggesting that we may select a
mutation’s site and substitution to finely tune the expected per-
turbation up or down.
Here, we used ET and a visual examination of the β2AR 3D
structures to identify residues that could underlie the specific
conformational rearrangements involved in the engagement of
distinct signaling effectors, thereby determining the structural
basis of β2AR functional selectivity. For the nine chosen residues,
we utilized EA to select mutations intended to differentially
perturb function, resulting in 28 single-site mutations. Their
signaling profiles in response to isoproterenol (ISO) were char-
acterized via cell-based assays on five different signaling path-
ways. Based solely on these experimental assays, non-negative
matrix factorization followed by k-means clustering groups the
mutations into three different phenotypical clusters, which are
not only defined by common signaling signatures but also
demonstrate shared conformational alterations, and EA scores.
These observations point to multiple motifs in determining sig-
naling specificity toward the different pathways engaged by the
β2AR, thus providing insights in the molecular determinants of
functional selectivity.
Results
Choice of mutations. Amino acids to be mutated were first
selected by determining the ET values of all transmembrane
domain β2AR residues using the previously described ET
method43. Given that intramolecular water molecules are known
to play a key role in regulating protein activity44–46, we con-
sidered ET values, as well as their distances to the water molecules
involved in hydrogen bond networks within the receptor struc-
ture to identify the residues to be mutated (Fig. 1, Supplementary
Table 1). In addition, we intentionally selected residues away
from the ligand binding pocket (except V86) to avoid interference
with ligand binding. Accordingly, the five residues (A782.49,
V862.57, L1243.43, I1273.46, and I2786.40—Ballesteros–Weinstein
numbering47 is given in superscript) with the highest ET ranking
that are located close to intra-protein water molecules and, for
four of them, distant from the ligand binding pocket were
selected. In order to assess the differential effects of mutation with
a range of impacts on these residues47, we selected substitutions
with a wide range of EA scores from low (<30), to moderate
(30–70), and to high impact (>70, Supplementary Table 1).
In addition to the ET-based selection, visual inspection of the
crystal structures of inactive and active β2AR lead us to also
consider a cluster of positively charged amino acids (K2736.35,
R3287.55, and R3338.51) (Fig. 1, Supplementary Table 1) pointing
outwards of the helix-bundle. The unusual orientations of these
residues that could be involved in helix 8 positioning prompted
us to substitute them to amino acids with distinct physicochem-
ical properties (A→L, K→R, or R→K). Finally, A2716.33, a residue
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pointing towards the G-protein binding pocket was substituted to
a bulky residue (W) or threonine (T) to assess their ability to
interfere with G-protein selective coupling.
Signaling profiles of β2AR variants. In order to examine the
effect of the mutations on the signaling profile of the β2AR, we
analyzed G-protein-dependent and -independent signaling
pathways. We monitored basal and ISO-induced Gs activation, Gi
activation and βarrestin engagement as well as their downstream
events (cAMP production and endocytosis; Fig. 2a). The
responses obtained for each pathway with WT receptor are illu-
strated in Supplementary Fig. 1a. Concentration response curves
were generated and normalized to WT β2AR for each pathway
and β2AR variant. Representative examples for mutations leading
to signaling signatures that are either similar to WT receptor or
altered for constitutive and/or agonist-stimulated activity of
specific pathways are shown in Fig. 2b. The entire data set for the
28 mutations is given in Supplementary Fig. 2. From these curves,
five signaling parameters were determined by curve fitting for
each pathway (Supplementary Fig. 1b, c). These parameters are
basal, lSO induced and maximal activity as well as pEC50 and
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Fig. 2 Signaling of the β2AR. a Simplified schematic of β2AR signaling pathways monitored in this study. b Concentration response curves of the five
monitored pathways for WT and three variants of β2AR to exemplify original data. K273A is representative of mutations that yielded a signaling profile
similar to WT whereas I127N exemplifies mutations increasing the constitutive activity of Gi that abrogate its ISO stimulation and reducing most of
βarrestin engagement and endocytosis whereas R328A exemplifies mutations in which Gi constitutive activity is increased and ISO stimulation is
abrogated but βarrestin and endocytosis are maintained. For each concentration response curve, the β2AR-unspecific response (value of cells only
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Fig. 1 Location of mutated residues in the β2AR. a 3D representation of WT β2AR structure (pdb: 2RH1). Mutated residues are shown as orange spheres.
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logΤ/KA; except for βarrestin engagement and endocytosis, where
no basal activity can be determined. Hence, the signaling profile
of each receptor variant is composed of 23 parameters (Supple-
mentary Tables 2–6).
Mutations within TM regions of GPCRs might influence the
stability of the receptor and thus the surface expression level.
Therefore, we closely monitored the cell surface expression of WT
and each β2AR variant in each experiment by cell surface ELISA
(Fig. 3a). About half of the introduced mutations reduced the
expression by ∼50%. Since we were unable to increase the cell
surface levels of these mutated receptors, we used incremental
amounts of WT β2AR to generate standard curves reflecting a
span of expression levels encompassing the expression levels of all
mutants for all signaling parameters determined (Supplementary
Fig 3). Hence, we were able to compare the signaling parameters
of receptor variants to interpolated parameters of WT β2AR at the
same expression level using normalized difference (see Fig. 3b
and “Methods” for details).
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Fig. 3 Normalizing to cell surface expression. a Surface expression as % of WT for WT and β2AR variants. The standard curve of WT β2AR was performed
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Clustering of β2AR variants based on their signaling profiles.
As shown in Fig. 2b and Supplementary Fig. 2, the mutations in
the β2AR lead to a large variety of changes in the signaling pro-
files. To identify commonalities among the signaling profiles, we
used non-negative matrix factorization (nnmf)48,49 and k-means
clustering to partition the mutations into the fewest groups within
which the assay profiles were most alike and between which they
were most distinct (Fig. 4a, b, Supplementary Fig. 4 and Sup-
plementary Table 7).
The signaling profile of the largest cluster (V86I/A, L124M,
I127V, A271T, K273R/A/L, I278V/L, R328K/H, R333L), cluster 1,
displays only minor changes compared to WT β2AR. In contrast
to cluster 1, cluster 2 (A271W, R328A/L, R333A) differs
significantly from WT β2AR. Whereas Gs signaling and cAMP
production were not appreciably affected, and βarrestin engage-
ment and endocytosis were only slightly reduced, the constitutive
activity toward Gi activation was considerably increased. The
change in constitutive activity was accompanied by a complete
loss of ISO-stimulated activity. This lack of responsiveness did
not result from a loss of binding ability of the ligand since ISO-
binding affinity was not affected (Supplementary Table 8) and the
agonist potency towards the other pathways was not affected.
Similarly, it did not result from a saturation of the assay since
higher activity levels could be detected for other β2AR variants
(ex: I278V and A271T, Supplementary Fig. 2). Similar to cluster
2, variants of cluster 3 (A78V/N/W, V86Y/D, L124S/G, I127N/G,
I278Q/S) also showed increased constitutive Gi activation and
loss of ISO responsiveness. The increase in basal activity was even
more dramatic than that observed in cluster 2, as it reached levels
that were higher than the maximal ISO-stimulated response
observed for WT receptor. In addition, the ISO-stimulated
βarrestin engagement and endocytosis of cluster 3 variants were
dramatically reduced and their constitutive activity toward Gs
activation was increased.
EA predicts the impact of mutations on phenotype. Ideally, if
clusters 1, 2, and 3 accurately distinguish three phenotypes, we
expect that EA scores should vary much less within each cluster
than between them. Indeed, compared to a random distribution,
EA scores are significantly closer within each group than between
any two of them (p value = 1.34 × 10−05). As expected, cluster 1 is
comprised of low, cluster 2 of medium, and cluster 3 of high EA
scores. The correlation between EA scores and phenotypic
mutational impact can be quantified by calculating the overall
phenotypic effect of each mutation compared to wild type
signaling, leading to R2 value of 0.74 (R = 0.86, Fig. 4c).
Structural analysis of mutated β2AR. We used in silico muta-
genesis and energy minimization to predict the structural changes
induced by the mutations. For this purpose, the changes in the
neighborhood of each mutation (residues entering and exiting a
4.5 Å radius around the mutation site) were predicted using the
Molecular Operating Environment (MOE) structure-based design
package50. The affected residues were then grouped according to
the phenotypical clustering of the mutations, and mapped on the
inactive and active X-ray structures of the β2AR (Fig. 5a). The
positions of the residues predicted to be affected for each of the
individual mutations are illustrated for both the inactive (Sup-
plementary Fig. 5) and active (Supplementary Fig. 6) receptor
conformations.
The perturbations promoted by mutations of cluster 1 were
dispersed throughout the receptor for both the inactive and the
active structure without any appearance of structural grouping.
The average number of residues affected by each mutation was
smaller in cluster 1 than either cluster 2 or 3 (Fig. 5b), consistent
with the modest functional consequences observed for these
mutations. The affected residues by the cluster 2 mutations
grouped in the lower third of the receptor’s TM domain, whereas
cluster 3 mutations and resulting perturbations were mainly
found around the middle of the receptor’s TM domain.
The activation process of GPCRs is conveyed by conforma-
tional rearrangements of key residues in microswitches. Hence,
we investigated whether the predicted clustered changes in cluster
2 and 3 neighbor known microswitches (PIF motif/connector,
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DRY motif, NPxxY motif, Toggle switch). For cluster 2, the
majority of the changes centered around the G-protein binding
site, which is flanked by the DRY and NPxxY motifs. The
alterations in cluster 3 occur both around the PIF motif as well as
the NPxxY motif (Fig. 6).
The prediction of structural changes is consistent with the
phenotypic clustering since mutations in the different clusters
resulted in distinct structural perturbations. Receptor variants in
cluster 2 that displayed increased constitutive Gi activity and loss
of ISO-induced Gi activation are characterized mainly by changes
around the G-protein binding site (DRY/NPxxY). For cluster 3
variants, which showed increased basal activity for both G-
proteins and also lost ISO-promoted Gi activation and βarrestin
engagement, mutations were predicted to affect the PIF and
toggle switches in addition to the NPxxY, consistent with a
greater functional impact.
These observations suggest that different regions of the
receptor may be important for the stabilization of different
receptor conformations causing preferential signaling through
various effectors.
Discussion
GPCR signaling is pleiotropic, and while the basis of GPCR
functional selectivity is not fully characterized, perturbations to
the structural conformation have been implicated in biased sig-
naling13,24,25,39,51. To better characterize the structure–function
relationship in GPCR signaling bias, we combined com-
plementary approaches including: computational predictions via
ET and EA analyses, experimental receptor signaling profiling via
BRET-based biosensors and molecular modeling. First, ET and
EA were combined to select and tune the intensity of mutational
perturbations at sequence positions that are themselves predicted
to be more or less functionally sensitive. Second, in order to
disentangle the heterogeneous signaling outputs typical of GPCR
signaling, we utilized BRET biosensors to characterize the
diversity of these pathways. Third, computational comparison,
through nnmf and clustering analyses, grouped the complexity of
each mutation’s response profile into a simpler and robust clas-
sification of the mutation’s global effect on the entirety of
receptor signaling profile rather than being limited to a specific
pathway-based analysis. Taken together, these steps therefore
form a comprehensive computational and experimental pipeline
to predict, test and validate mutationally induced receptor bias
allowing targeted site-specific mutagenesis and reengineering of
receptor function. While we have demonstrated this approach
within the β2AR, all the methodologies used were designed for
application in any protein and therefore represent a high
throughput methodology to interrogate structure–function
relationships.
In this study, we demonstrated the pipeline’s efficacy to char-
acterize perturbations to the β2AR signaling profile using 28
single-site mutations at nine different structural positions
important to receptor function. These 28 mutations clustered into
three different major phenotypic outcomes: (i) minimal pertur-
bation compared to WT signaling, (ii) increased basal activity for
Gi activation together with loss of ligand-induced Gi activation,
and (iii) increased basal activity for G-protein activation and loss
of both ligand-induced Gi and βarrestin responses. Noticeably,
only a few mutations affected agonist-stimulated Gs activity so
that it did not contribute to the clustering (Supplementary Fig. 4).
Strikingly, we note a highly significant trend between predicted
impact by EA and actual phenotypic perturbation (Fig. 4c), as
previously shown in a retrospective analysis31. EA is a first
principle equation for evolution. It uses calculus, the mathema-
tical language for the study of variations, to formally link geno-
type variations, or mutations, to their effect on phenotype or
functional readouts. Our results show that even in a multi-
functional system as complex as GPCRs, the EA score accurately
quantifies the impact of coding mutations on the loss of down-
stream signaling. EA predictions are validated both on the broad
scale, capturing the overall phenotypic change and correlating
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with the cluster assignments, and on the small scale, as individual
mutations at the same structural position result in different sig-
naling biases depending on the severity of the mutation. This
trend is exemplified by V86I (EA score of 26), V86A (53), V86Y
(73), and V86D (90) (Supplementary Fig. 4) where we see a
gradual increase in experimental signaling perturbation as a
function of increasing EA scores, substantiating the notion that
different receptor conformations engage different effector pro-
teins. We do however note that mutations within cluster 1 deviate
from the linear correlation, with some EA predictions being
higher than their measured phenotypic response. This is most
likely due to the fact that the lower impact of these mutations
cannot be detected experimentally by the assays used. We can
speculate that either the assays were not sufficiently sensitive to
detect the signaling impact or that these mutations affect a sig-
naling pathway that was not assessed in the present study.
Mutations predicted to have a low impact all caused minimal
modulation of β2AR signaling and clustered together in cluster 1.
The weakness of this biological perturbation is consistent with the
relatively minor structural alterations to the β2AR structure
inferred from structural modeling. Thus, a native-like structural
conformation exhibits wild-type-like signaling.
Medium impact mutations in cluster 2, as expected, show
moderate signaling changes correlating to structural perturba-
tions mainly affecting the Gi pathway, both in the basal and the
ISO-induced activity. In agreement with previous findings on EA,
these mid-range mutations (EA around 50) only perturb specific
aspects of protein function rather than have a universally dele-
terious effect. Interestingly, the predicted structural changes for
these mutations are centered around the active conformation of
the G-protein binding site, including the NPxxY and DRY motif.
While the R1313.50 of the DRY motif has been implicated in
direct binding of the G-protein11,14, the shape of the G-protein
binding pocket itself also plays a role in G-protein binding and
potentially in G-protein selectivity. Recently, it has been sug-
gested that the position of TM6 determines G-protein specificity.
A smaller G-protein binding pocket would favor Gi binding due
to its slimmer C-terminus, whereas a larger G-protein binding
pocket favors Gs binding52. Given their impact around both the
DRY motif and the G-protein binding pocket, the predicted
alterations induced by the mutations in cluster 2 might allow
TM6 an easier transition towards the Gi active state thereby
explaining increased basal activity. Furthermore, the fact that no
increase in Gi activation can be induced by ISO indicates that the
fraction of receptors in active state is ligand independent, sug-
gesting a mutation-induced receptor conformation that is
uncoupled from the “normal” allosteric regulation of the Gi
pathway during receptor activation.
High impact mutations in cluster 3 share a signaling bias
against agonist-promoted Gi- and βarrestin-signaling and an
increased basal Gs and Gi activity. Cluster 3 mutations are pre-
dicted to promote similar alterations in the active state G-protein
binding site (albeit more centered around the NPxxY than the
DRY motif) as cluster 2, which likely contributes to the increased
basal activity and reduced ISO-induced activity towards Gi acti-
vation. However, the drastically increased constitutive Gi and Gs
activity and loss of agonist-promoted βarrestin engagement sug-
gest other causes. Across all mutations in cluster 3, we note a
significantly altered structural conformations around the PIF and
NPxxY motifs, which are not present in cluster 1 or 2. Structural
rearrangements in the PIF motif during activation have been
described for various receptors (β2AR10,23, 5HT13, μOR46). So far,
these rearrangements have been loosely associated with G-protein
signaling13, however, no in depth functional analysis on this motif
has been performed. The NPxxY motif in TM7 was shown to be
important for normal receptor function, including G-protein
signaling and receptor internalization53,54. Furthermore, the
conformation of TM7 was linked to βarrestin engagement13,24,55.
Our results are in agreement with these analyses and implicate
both the PIF and NPxxY motifs in disruption of receptor sig-
naling, constitutively active G-protein activation, and the elim-
ination of βarrestin signaling.
Within cluster 3, some mutations exclusively affect the NPxxY
motif while others only affect the conformation of the PIF motif
(Supplementary Figs. 5 and 6), yet all mutations within this
cluster have a conserved phenotype in regards to the Gi and
βarrestin pathway. These data suggest that alterations in either
motif are sufficient to cause the observed biased signaling profile.
Given the nature of the PIF motif to transduce signal from the
ligand binding event through the TM region, we cannot exclude
NPxxY involvement in mutations that only affect the PIF motif. It
is possible that the alterations of the PIF motif result in an
identical phenotype to alterations directly to the NPxxY motif
due to a coupling of PIF to the NPxxY motif. An alternative
explanation is that disruptions to the PIF motif cause phenotypic
alterations independent of the NPxxY motif, indicating that dif-
ferent receptor conformations might have the same signaling
output. Another possibility is that the PIF and the NPxxY motifs
act in parallel and that both rearrangements are needed for some
of the signaling activity. Hence, alterations to either one of these
two microswitches could result in the same functional outcome.
Regardless, our data, in agreement with prior research, implicates
both the PIF domain and the NPxxY motif in receptor activation
and signaling through Gi and βarrestin. Additionally, these data
suggest a novel function of the PIF motif in modulating the
activation of βarrestin signaling in concert with the NPxxY motif.
These results highlight the power of EA to inform future
mutagenesis and receptor engineering by quantifying the expec-
ted impact a mutation has on protein function. Designed muta-
tions can therefore potentially be fine-tuned to the desired
impact, thereby reducing time spent on random mutagenesis to
achieve a desired function. This is illustrated by the fact that when
transfering three substitutions (I to V, L or Q) at position I6.40
from the β2AR (I278) to the vasopressin type 2 receptor (V2R)
(I276), we found that, as was the case for the β2AR, the I276V/L
variants had no or modest effects on either Gs activation, cAMP
production or βarrestin recruitment whereas I276Q considerably
and selectively affected βarrestin recruitment (Supplementary
Fig. 7).
The approach followed in the present study has obvious
implications for a possible understanding of the structural
determinants of ligand-biased signaling. Further studies assessing
the effects of mutations selectively affecting Gi or βarrestin
engagement on the activity of βarrestin- or G-protein-biased
ligands should shed new light on the specific and/or local con-
formational rearrangements required to engage specific signaling
effectors. Structural studies have already highlighted that ligands
with distinct functional selectivity profiles result in distinct
receptor conformation26,56,57. Based on NMR signals, Liu et al.24
reported that β-arrestin-biased ligands predominantly impact the
conformational states of TM7. Interestingly, mutations selectively
affecting βarrestin engagement (cluster 3) are predicted to have
more impact on residues close to the PIF and NPXXY than the
DRY motif. Assessing how these mutations may affect the
movement of TM7 upon binding of balanced and biased ligands
will be of considerable interest.
In summary, we have developed a comprehensive methodology
capable of guiding site-directed mutagenesis studies and protein
reengineering by coupling in silico evolutionary lineage analysis
with biological characterization and collaborative filtering clus-
tering techniques. Using this approach, we demonstrate a strong
correlation between our computational predictions stemming
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from evolutionary history, the actual biological perturbations and
structural determinants thereof. Additionally, EA enables the
design of mutations at the same position, which vary gradually in
functional effect and magnitude, in effect tuning them like a turn
of a rheostat. Even though our designed mutations did not occur
directly within the functional motifs, the resulting structural
changes altered key functional microswitches, further demon-
strating the power of this approach to arrive at non-obvious
solutions to signaling perturbation. Through this validation, we
have gained a better understanding of the molecular determinants
of biased GPCR conformations, a crucial first step for the
development of biased ligands that activate only beneficial path-
ways thereby reducing pharmacological side effects and predict-
ing how clinically relevant mutations result in altered cellular
signaling leading to disease progression.
Methods
Reagents. (-)-Isoproterenol hydrochloride (ISO) was purchased from Sigma
Aldrich (St. Louis, MO, USA). Coelenterazine 400a was purchased from NanoLight
Technology (Pinetop, AZ, USA). All cell culture reagents were bought from Wisent
(St-Bruno, QC, Canada).
Plasmids. Single-site mutations in the β2AR and V2R were introduced via PCR
with QuickChange Site-directed Mutagenesis Kit (Agilent Technologies, Santa
Clare, CA, USA) following the manufacturer’s instructions. All β2AR variants were
verified by sequencing. Receptor constructs contained an Ha tag at their N-ter-
minus, as previously described58,59, to facilitate the quantification of cell surface
expression by ELISA.
For creating a unimolecular biosensor for monitoring βarrestin recruitment,
GFP10 coding sequence (cds) without stop codon was PCR amplified with a
forward primer encoding the plasma-membrane targeting sequence from the Lyn
Kinase and a small linker (MGCIKSKGKDSLSNA), RlucII cds without stop codon
was PCR amplified and both fragments assembled in pCDNA 3.1 Zeo(+) using In-
Fusion (Clontech Laboratories, Mountain View, CA, USA), creating pCDNA3.1
Zeo(+) Lyn-GFP10-RlucII. The cds of a structurally disorganized 300 residues-long
linker, previously described (Dis300LNK)60, was subcloned in between GFP10 and
RlucII, creating pCDNA3.1 Zeo(+) Lyn-GFP10-Dis300LNK-RlucII. The cds of
βarrestin2 was PCR amplified using forward primers encoding a small flexible
linker (GSGSAGTA) and inserted at the C-terminus of RlucII, creating pCDNA3.1
Zeo(+)βarr2 trans constructs.
Cells, cell culture, and transfections. BCM3 is a clone of the HEK293T cell line
in which BRET-based biosensors have been developed in Dr Bouvier’s laboratory
and was used for all the BRET and ELISA experiments. Cells were regularly tested
for mycoplasma contamination (PCR Mycoplasma Detection kit, abm, BC,
Canada) and only mycoplasma-negative cells were used for the assays.
HEK293T cells were grown at 37 °C with 5% CO2 in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum.
HEK293T cells were transiently transfected (500,000 cells per well) in six-well
plates with biosensors for bioluminescence resonance energy transfer (BRET)
assays and ELISA with X-treme GENE 9 DNA Transfection Reagent (Transfection
Reagent:DNA ratio: 3:1; Roche Diagnostics, Indianapolis, IN, USA). Cells were re-
plated (50,000 cells per well) 24 h post transfection into white 96 well Culture
Plates (Greiner Bio-One GmbH, Frickenhausen, Germany) coated with poly-L-
ornithine. The day of the experiment, cells were washed twice with stimulation
buffer (Modified Hank’s Balances Salt Solution (HBSS): 137 mM NaCl, 5.4 mM
KCl, 0.25 mM Na2HPO4, 0.44 mM KH2PO4, 1.8 mM CaCl2, 0.8 mM MgSO4, 4.2
mM NaHCO3, 0.2% (w/v) D-glucose, pH 7.4).
The activity of each signaling pathway was measured in living cells using BRET-
based assays described below. Optimal times of measurement following agonist
stimulation were determined from time-course experiments carried out for each
assay for the WT receptor. Times for which maximal responses was achieved and
stable for a given assay were selected and were 5, 15 and 30 min for G-protein
activity, βarrestin recruitment and cAMP production assays, respectively. The
ELISA-based endocytosis assay was carried out 60 min following agonist
stimulation.
Gs- and Gi-activation assay. HEK293T cells were co-transfected with varying
amounts of WT or β2AR variants (250 ng per well) and a three-component G-
protein activation biosensor composed of Gα-RlucII (Gαs-67-RlucII (5 ng per well)
61 for Gs activation or Gαi2-99-RlucII (1 ng per well)62 for Gi activation), Gβ1 (100
ng per well), and GFP10-Gγ1 (25 ng per well) as described above. Coelenterazine
400a, diluted in stimulation buffer (final: 2.5 µM) was added to the wells for 6 min,
then ISO, diluted in stimulation buffer, was added at the indicated concentrations
to the wells for 5 min. Plates were read on the Mithras LB 940 (Berthold Tech-
nologies, Bad Wildbad, Germany), for 1 s per well, with filters set at 410± 70 nm
(RlucII) and 515± 20 nm (GFP10) and BRET ratios were calculated as GFP10
divided by RlucII. Upon formation of the Gα-RlucII:Gβ1:GFP10-Gγ1 hetero-trimer,
a significant BRET signal is detected resulting from the proximity between Gα-
RlucII and GFP10-Gγ1. Upon activation of Gα, the separation between the Gα and
Gβγ subunits leads to a decrease in BRET61.
cAMP production assay. HEK293T cells were co-transfected with varying
amounts of WT or β2AR variants (200 ng per well) and BRET-cAMP biosensor
(GFP10-mutEPAC1-RlucII; 1 ng per well)63. The indicated concentrations of ISO,
diluted in stimulation buffer, were added to the wells for 30 min, then coelenter-
azine 400a, diluted in stimulation buffer (final: 2.5 µM) was added to the wells for 5
min. Plates were read on the Mithras LB 940, as described above. Upon binding of
cAMP, EPAC undergoes a conformational change leading to a significant decrease
in the observed BRET signal.
βarrestin2 recruitment. HEK293T cells were co-transfected with varying amounts
of WT or β2AR variants (250 ng per well) and the BRET-βarrestin2-recruitment
biosensor (βarr2 trans constructs, 2 ng per well). The indicated concentrations of
ISO, diluted in stimulation buffer, were added to the wells for 15 min, then coe-
lenterazine 400a, diluted in stimulation buffer (final: 2.5 µM) was added to the wells
for 5 min. Plates were read on the Mithras LB 940, as described above. Upon
recruitment of βarrestin2 to the receptor, a significant increase in BRET signal is
observed resulting from the increased proximity between RlucII and GFP10 upon
translocation of the βarrestin to the stimulated receptor.
Endocytosis. HEK293T cells were transfected with WT or β2AR variants (50 ng
per well) as described above. The indicated concentrations of ISO, diluted in sti-
mulation buffer, were added to the wells for 60 min, then a cell surface ELISA was
performed. In short, cells were fixed with 3% paraformaldehyde for 10 min. Cells
were washed three times in washing buffer (modified HBSS (see above) +0.5%
BSA), then cells were incubated for 60 min with anti-HA-peroxidase antibody
(12013819001, Roche Diagnostics, Indianapolis, IN, USA) (1:1000 in washing
buffer). Cells were washed three times in washing buffer. ECL (1:1 ratio; Perkin
Elmer, Waltham, MA, USA) was added to the wells and plates were read on the
Mithras LB 940, for 1 s per well, with no filters.
Cell surface expression. In order to monitor cell surface expression of WT or
variants β2AR transfected cells used for BRET or endocytosis assays, cell surface
ELISA was performed on cells re-plated 24 h post transfection, as for endocytosis
experiments but without ISO stimulation.
Analysis of concentration response curves. In order to correct for β2AR-
unspecific response, the value of cells only transfected with the biosensor (no
receptor added) was subtracted from the experimental value. For each repeat of the
assays, data were normalized as percentage of WT β2AR maximal ISO-stimulated
response (Supplementary Fig. 1b, c). Signaling parameters: basal activity, maximal
activity, ISO-induced activity, and pEC50 were determined by fitting the con-
centration response curve to Eq. (1):
E ¼basalþ max basal
1þ 10ðlogEC50½AÞn ; ð1Þ
where E is the effect of the ligand, [A] is the concentration of the ligand, max is
the maximal response, basal is the non-stimulated response, and n is the slope of
the transducer function that links occupancy to response.
The signaling parameter log Τ/KA was determined by fitting the concentration
response curve to Eq. (2):
E ¼ basalþ max basal
1þ
10½A
10logKA
þ1
10logR ´ 10½A
 n ; ð2Þ
where E is the effect of the ligand, [A] is the concentration of the ligand, max is
the maximal response, basal is the non-stimulated response, logKA denote the
logarithmic functional equilibrium dissociation constant of the ligand, n is the
slope of the transducer function that links occupancy to response, and logR is the
logarithm of the “transduction coefficient”, Τ/KA, where Τ is an index of the
coupling efficiency of the agonist. For detail see refs. 64,65
In Eqs. (1) and (2), n was fixed to the determined value for WT β2AR and basal
was not fixed. In Eq. (2) max was shared for all data sets. Values of n for WT β2AR
used in the fitting are given in Supplementary Fig. 1.
Correction for cell surface expression. For each assay, a concentration response
curve for WT β2AR using 5–150% of DNA amount were prepared and the cell
surface expression was measured. The signaling parameters (basal activity, max-
imal activity, ISO-induced activity, pEC50, and log Τ/KA) were determined and
their correlation to the expression level was calculated (Fig. 3b). If R2 was higher
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02257-x ARTICLE
NATURE COMMUNICATIONS |8:  2169 |DOI: 10.1038/s41467-017-02257-x |www.nature.com/naturecommunications 9
than 0.3, a linear correlation was presumed and a “theoretical WT value” with the
surface expression level of each mutant was calculated using the determined
equation. If R2 was lower than 0.3, the average of all values was used as “theoretical
WT value”. In order to compare the signaling parameters of β2AR variants to WT
β2AR, Eq. (3) was used:
Δnorm ¼ mutWTtheoreticalmutþWTtheoretical ; ð3Þ
where Δnorm is the normalized difference, mut denotes the value of the β2AR
variant, and WTtheoretical corresponds to the interpolated value obtained from the
WT receptor titration curves obtained for each pathway (Supplementary Fig. 3,
Fig. 3). This normalization, which yields values between −1 and +1 (WT being 0 by
definition) was done in order to allow direct visual comparison between the
parameters without having different scales. Δnorm is then plotted for each
parameter as the radius of the radial graph.
Evolutionary trace analysis. To identify functional residues, ET takes a set of
homologs as input. Due to the variation in the GPCR loop regions, we focused
solely on the transmembrane domains, a total of 195 residues. The multiple
sequence alignment of the transmembrane region was made up of 2512 Class A
GPCRs, excluding olfactory receptors, and constructed as previously described37.
The sequences were gathered from the GPCRdb database (http://gpcrdb.org/) and
included sequences from mammals, amphibians, reptiles, fish, birds, echinoderms,
and protostomes. To select key functional amino acids, the ET results were pro-
jected on to the protein structure for β2AR (pdb: 2RH1). Targets were chosen based
on their ET scores, their distance to the ligand and to the intramolecular waters.
Evolutionary action scores. EA represents a first principle equation describing the
fundamental basis for evolution by providing an evaluable Eq. (4) connecting the
changes in genotype to their phenotypic effect:
dφ ¼ ∇f dγ; ð4Þ
Formally the change in phenotype (dφ) is equal to the evolutionary fitness
gradient at that position (dγ), calculated by ET, multiplied by the magnitude of the
substitution made, calculated by the log odds of the substitution (∇f )31, which is
dependent on the ET score of that position and any available secondary structural
information. A unique set of log odds is therefore calculated for every permutation
of ET score bins (e.g., EA=1–10 or EA=10–20) with the available secondary
structure information (e.g., helix, beta-sheet or coil). When structure is not
available, a purely sequence-based EA score is used.
Robustness of the clustering method. In order to establish robustness of the
clusters, we propagated random experimental error through the clustering proce-
dure. To accomplish this, we generated 1000 matrices (28 mutation×29 pheno-
types, 5 pathways×6 parameters (basal, max, ligand induced, EC50, log T/Ka, with
no basal for barr) by randomly sampling, for each phenotype data point, a single
value from the normal distribution with the mean and standard deviation esti-
mated from the mutation replicates. Each point was then normalized using the
normalized difference detailed above. We then performed the clustering method,
detailed below, independently on each of the 1000 sampled matrices. Finally, we
quantified how frequently each mutation clustered together in each of these 1000
runs, which resulted in a clustering frequency matrix (28 mutations×28 mutations).
To obtain final cluster assignments and create the similarity dendrogram, the
frequency matrix was converted to a distance matrix using Pearson’s correlation as
a measure of similarity with final cluster designation assigned via hierarchical
clustering.
For each independent run using a corresponding sampled matrix, we utilized
multiple iterations of non-negative matrix factorization (nnmf)48,49 to cluster β2AR
variants based on their signaling signature and their expression. Prior to
factorization, values were normalized within each column (assay phenotype
measurement) on a scale of 0–1 using Eq. (5)
normalization ¼ mutmin
maxmin : ð5Þ
where mut denotes the value of the β2AR variant and max and min represent
the maximal and minimal values for each column. This normalization was
necessary to prevent differences in phenotype scale from biasing the feature
reduction step. The resulting mutant×phenotype was deconstructed into its basis
vectors [W,H] (where W has the dimensions 28 mutations by k, and H has the
dimension k by 28 signaling parameters and expression levels) using the
multiplicative algorithm of nnmf with 500 replicates. Cluster assignment was
performed using k-means on the W basis vector where k equaled the number of
features used by nnmf. This methodology was then repeated 100 times to measure
how frequently any two mutations clustered together, resulting in a mutation by
mutation frequency matrix with each value being the frequency that two mutants
co-clustered (Supplementary Table 7). This frequency provides a similarity
measure between any two mutants.
Cluster assignment for each of the 1000 sampled matrices was conducted
independently using the Pearson’s correlation method. This cluster assignment for
each sampled matrix was then used for the final clustering frequency matrix,
detailed above.
We performed this analysis with k = 2 up to k=7 to identify the optimal
number of clusters to accurately describe the data. The intermediate frequency
matrix enabled a measure to quantify clustering robustness. Specifically,
cluster assignments with frequencies equal to 0% and 100% indicate very robust
and distinct assignments as mutations do not jump around between multiple
clusters.
EA score clustering. For each k, we performed 10,000 random simulations
permuting the EA scores for all mutations and measuring the variation between
EA score in each cluster, where variation=EAi-EAj for all combinations of EA
scores within that cluster. All of these values were appended into an array and
compared to the phenotypic clusters using a Kolmogorov–Smirnov test. This
process was repeated 10,000 times and the average P value was used to determine
significance.
Structure prediction and analysis. Protein structure prediction of the mutated
receptors was performed using the MOE structure-based design package50. First for
both active and inactive receptor templates (2RH1 and 4LDE), the automated
structure preparation protocol Protonate3D66 was run. Protonate3D calculates the
optimal protonation states, including titration, rotamer and “flips” using a large-
scale combinatorial search. Using Residue Scanning in the Protein Design panel,
the intended mutations were inserted. The selection of side chain conformations is
made from a rich rotamer library followed by a refinement protocol based on force
field energy minimization. For this purpose, the AMBER12EHT force field was
used.
Structural predictions were then visualized using the chimera visualization
system67. Residues within 4.5 Å of the mutations sites were identified via chimera
both in WT and mutated receptors. By comparing these environments, changes in
their amino acid composition (both entering and existing amino acids within this
4.5 Å radius) were detected. Additionally, it was analyzed with chimera which of
these changes appeared within 4.5 Å of known microswitches. Detected changes
were back projected on the 3D structure and highlighted as indicated in the figure
legends.
Data analysis. Data analysis was performed using Microsoft Excel (Microsoft,
Redmond, WA, USA), GraphPad Prism (versions 6, GraphPad Software, La Jolla,
CA, USA) MATLAB and Statistics Toolbox Release 2014b (The MathWorks, Inc.
Natick, MA, USA), and NumPy and SciPy packages68.
BRET-based binding assay. Nluc (Promega, Madison, WI, USA) was inserted N-
terminally into WT β2AR using the Gibson Assembly Kit (NEB, Ipswich, MA,
USA) according to manufacturer’s instruction. Both domains were joined by an
eight amino acid Gly-Ser-linker. In order to improve expression, the reported
export signal69 was added to the construct. The signaling and binding properties of
the construct were verified (Supplementary Fig. 8). Single-site mutations in the
β2AR were introduced as described above.
HEK293T cells were transfected with Nluc-β2AR WT or variants (100 ng per
well) as described above. Cells were re-plated (50,000 cells per well) 24 h post
transfection into white 96 well cellGrade Plates (Brand GmbH und Co KG,
Wertheim, Germany) coated with poly-L-ornithine. Cells were washed twice
with stimulation buffer (Modified HBSS: mentioned above). 100 nM
(S)-propranololol-green (labeled with BODIPY-FL; CellAura, Winscombe, UK)
and increasing concentrations of ISO, diluted in stimulation buffer, were added to
the wells for 30 min, then coelenterazine 400a, diluted in stimulation buffer
(final: 0.1 µM) was added to the wells directly before reading. Plates were read on
the GloMax® 96 Microplate Luminometer (Promega, Madison, WI, USA), for 0.5 s
per well, with filters set at 465± 25 nm (Nluc) and 530 longpass (BODIPY-FL).
BRET ratios were calculated as BODIPY-FL divided by Nluc. Upon binding
of the fluorescent ligand to the Nluc-tagged receptor, a significant BRET
signal is detected. The non-labeled ligand displaces the fluorescent ligand
leading to a decrease in the BRET signal. The binding affinity of ISO was
determined from the IC50s of the ISO-promoted decrease in propranolol-green
binding for each variant.
Data availability. The authors declare that all data supporting the findings in this
study are presented within the article and its Supplementary Information Files, and
are available from the corresponding author upon request.
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